SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection.
N Engl J Med. 2022 Jan 20;386(3):220-229. doi: 10.1056/NEJMoa2106516.
N Engl J Med. 2022.
PMID: 35045228
Clinical Trial.